Redirected from Fast-track
See U.S. Trade Promotion Authority Act.
Fast track is also an FDA program that expedites development and testing for an experimental[?] drug that treats a serious or life-threatening medical condition for which no other drug either exists or works as well. The status applies to the set of a product and the associated condition it helps. The FDA will accept partial results for fast track drugs undergoing testing to speed up an approval decision. As an example, the drug that lessens peanut allergies, TNX-901, received fast track status during its testing, even though other products exist to reduce allergic symptoms in general.
Search Encyclopedia
|
Featured Article
|